Brought to you by 
Series B results in $17.5mm for ArKal Medical
17 Sep 2008
Executive Summary
ArKal Medical (glucose monitoring) brought in $17.5mm through its Series B financing round led by Thomas McNerney & Partners, with additional participation from returning shareholders Delphi Ventures and MedVenture Associates.
Deal Industry
- Medical Devices
-
Medical Devices
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Glucose Testing
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series B results in $17.5mm for ArKal Medical
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice